Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1167443
Abstract: In the last years, the tumor microenvironment (TME) has emerged as a promising target for therapeutic interventions in cancer. Cancer cells are highly dependent on the TME to growth and evade the immune system. Three… read more here.
Keywords: cell; blood cancers; immunotherapy blood; cell immunotherapy ... See more keywords